Using Platelet-Rich Plasma for De Quervain’s Tenosynovitis
Author Information
Author(s): Muacevic Alexander, Adler John R, Alam Mahmood, Merza Abdulla Mohamed Ayman, Alawainati Mahmood, Haider Fayza
Primary Institution: Salmaniya Medical Complex, Manama, BHR
Hypothesis
Is platelet-rich plasma (PRP) an effective treatment for De Quervain’s tenosynovitis?
Conclusion
Platelet-rich plasma is a promising and safe alternative to steroid injections for treating De Quervain’s tenosynovitis.
Supporting Evidence
- PRP injections may enhance healing by delivering growth factors to the injury site.
- Studies show PRP can be as effective as or better than steroid injections for pain relief.
- Most studies included in the review had small sample sizes, affecting the strength of the conclusions.
Takeaway
Doctors are trying a new treatment called platelet-rich plasma (PRP) for a wrist problem that makes it hurt to move. It seems to help more than the usual medicine.
Methodology
A systematic review of literature from January 2013 to October 2023, including a search through multiple databases and manual searches, evaluating studies on PRP for DQVD.
Potential Biases
Potential bias due to non-randomized studies and variability in assessment methods.
Limitations
Variability in study designs, PRP preparation methods, and lack of control groups in some studies limit the generalizability of findings.
Participant Demographics
Studies included a mix of males and females, with a predominance of females in most studies.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website